ReviewExploration of targeted anti-tumor therapy2024

Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach.

Francesca Di Pressa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.